These significantly enriched GO terms and KEGG pathways could help us deeply understand the function of SLC16A1 and SLC16A3, which are involved in the occurrence and progression of pancreatic cancer. This evidence concerns the gene SLC16A3 and familial pancreatic carcinoma.